Abstract
Farming of Salmon has become a significant industry in many countries over the past two decades. A major challenge facing this sector is infestation of the salmon by sea lice. The main way of treating salmon for such infestations is the use of medicines such as organophosphates, pyrethrins, hydrogen peroxide or benzoylphenyl ureas. The use of these medicines in fish farms is, however, highly regulated due to concerns about contamination of the wider marine environment. In this paper we report the use of photochemically active biocides for the treatment of a marine copepod, which is a model of parasitic sea lice. Photochemical activation and subsequent photodegradation of PDAs may represent a controllable and environmentally benign option for control of these parasites or other pest organisms in aquaculture.
Introduction
The culture of Atlantic salmon (Salmo salar) has become a significant industry in countries from both hemispheres over the past 20 years, but in several countries environmental concerns have become significant constraints to further development [1] . The efficiency of the industry has improved with increasing production levels, and husbandry and management techniques continue to advance. Further expansion of the industry in Europe, Canada and Chile, however, is still threatened by the proliferation of ectoparasitic sea lice. Sea lice belonging to the genera Lepeophtheirus and Caligus (Caligidae: Crustacea) are naturally occurring ectoparasitic copepods of salmonids. Major infestations can weaken the salmon resulting in the development of secondary infections, the transmission of microbial pathogens, and higher mortality rates. In addition, the market value of the fish may be reduced due to unsightly lesions [2] . Sea lice can be transmitted between farmed and wild populations of both salmon and sea trout (Salmo truta) [3] , thus there are strong pressures from conservationists and regulators to keep lice numbers on farmed fish to a minimum.
Economically viable salmon farming would not be possible without controlling parasitic infestations using medicines [4] , which are administered to caged salmon as bath immersion treatments or in salmon feed. A range of compounds with differing modes of action have been, or are still being used for the control of sea lice on commercial salmon farms worldwide. These included two organophosphates (dichlorvos, Salmosan); three natural pyrethrin/pyrethroid compounds (pyrethrum, Excis, deltamethrin); one oxidizing agent (hydrogen peroxide); three avermectins (ivermectin, emamectin, doramectin) and two benzoylphenyl ureas (teflubenzuron, diflubenzuron). Bath immersion treatments are administered to lice infected salmon by surrounding a cage with a tarpaulin, which is removed at the end of the treatment, releasing the solution into the surrounding water where it disperses in the direction of prevailing current flow. In-feed treatments are administered to salmon incorporated into feed, and may enter the marine environment either directly from waste feed, indirectly via faeces during the treatment period or by egestion post-treatment. Because of the non-specific toxicity and potential environmental impacts of the currently available sea lice treatment medicines, they are highly regulated to reduce the likelihood of adverse affects on the surrounding marine environment. Consequently, commercial salmon farm production may be limited by the amount and type of treatment agent that farms are licensed to use during a production cycle.
Therefore, a sea lice treatment agent that is highly specific but looses its toxicity following treatment so that it does not adversely affect the wider marine environment when it is released would be beneficial both for the industry and the environment.
Photodynamic therapy employs the combination of light and a drug to bring about a cyto-toxic or modifying effect to cancerous or otherwise unwanted tissue [5, 6] . A photosensitiser which exhibits negligible toxicity in the dark is introduced into the body and accumulates preferentially in rapidly dividing cells. When the photosensitiser attains an appropriate ratio of accumulation in diseased versus healthy tissue, a carefully regulated light dose is applied to the diseased tissue. The light activates the photosensitiser and elicits its toxic action [6, 7] . PDT is dependent on the presence of molecular oxygen [7] . This suggests that singlet oxygen generated by the photosensitisation of molecular triplet oxygen is the principal toxic species produced during PDT, although the extent to which this species is responsible for the photodynamic effect is under debate [8, 9] . Nonetheless, the generation of singlet oxygen is extremely crucial to the success of PDT, and one of the first tests performed on potential PDT compounds is an investigation of their ability to produce singlet oxygen [9] .
Methylene Blue (MB) and Nuclear Fast Red (NFR) are two known photosensitisers. MB is a phenothiazinium dye whose efficacy against the methicillin-resistant Staphylococcus aureus (MRSA), a major cause of nosocomial infection [10] , has been investigated. The uptake of dyes and stains by bacteria has long been used in their detection, and several such dyes are inherently bactericidal [11] . Studies on the use of phenothiazines in the photodynamic therapy of cancer have concentrated predominantly on MB and its demethylated analogues azure C, thionine and toluidine blue [12] . MB exhibits phototoxicity toward a variety of tumour cell lines in vitro [13] [14] [15] [16] [17] [18] .
NFR is an anthraquinone dye, and a number of anthraquinones, both synthetic and naturally occurring, have been screened for their anti-tumour activity in a variety of animal test systems [19] [20] [21] . Many such anthraquinone derivatives possess the ability to mediate single electron transfer to molecular oxygen to form a superoxide anion radical and to generate reactive oxygen species (ROS) when stimulated by visible light [22, 23] .
Photosensitive compounds may offer an environmentally friendly alternative to the compounds currently used to control sea lice on salmon farms. We have previously reported the use of methylene blue (MB) and nuclear fast red (NFR) as biocides in the treatment of algae and cyanobacteria [24] [25] [26] .
This paper presents the results of an assessment of the suitability of these two photosensitisers, including bioassays with the copepod Acartia clausi, to assess their toxicity following light activation.
The marine copepod Acartia clausi was used as a model organism in place of sea lice to assess the toxicity of light activated MB and NFR. A. clausi belongs to the same Subclass (Copepoda) as sea lice, but unlike the target organism, Lepeophtheirus Salmonis, is easily cultured in the laboratory, and has also been used previously to assess the toxicity of sea lice treatment medicines [27, 28] . Given the close relationship and similarity in life cycles of the two species, A. clausi was considered to be an appropriate substitute in this preliminary assessment of the potential use of photoactivated biocides to control sea lice.
Materials and Methods

Materials
Methylene Blue (85%) was purchased from Fisher Scientific, Nuclear Fast
Red was purchased from Sigma and 1,3-Diphenylisobenzofuran (97%) was purchased from Aldrich. The photosensitisers were prepared in 0.2 µM GF/C filtered sea water. 1,3-Diphenylisobenzofuran was prepared in methanol.
Acartia clausi were collected using vertical hauls of a 120 µm zooplankton net from sea lochs on the west coast of Scotland close to Dunstaffnage Marine Laboratory, Oban. On return to the laboratory, adult copepods were sorted and identified according to Sars [29] . They were transferred into culture 
Photochemical reactions
Aqueous solutions of Methylene Blue (MB) (10 µM) and Nuclear Fast Red (NFR) (10µM) were prepared from stock solutions. A solution of each dye (50 
Singlet oxygen determinations
The yields of singlet oxygen for MB and NFR were determined using the 1,3-Diphenylisobenzofuran (1,3-DPBF) bleaching method [31, 32] . 1,3-DPBF is an established singlet oxygen scavenger and through the decrease in 1,3-DPBF absorption, monitored spectroscopically, the efficiency of the dyes at generating singlet oxygen could be subsequently monitored. Solutions of the photosensitisers (MB and NFR) and 1,3-Diphenylisobenzofuran (1,3-DPBF)
were illuminated under visible light. The rate at which the furan was 
Copepod toxicity tests
The toxicity of each PDA and a "cocktail" of MB/NFR (25:75) to the marine copepod A. clausi were investigated in 24 h static tests. Adult copepods were The toxicity of the PDAs to adult copepods following light-activation was assessed as described above, but with the inclusion of a 1 h exposure period to white light to activate the PDAs. Adult copepods were exposed to the same range of PDA concentrations as above under ambient light. After an initial exposure period of 1 h the test chambers were placed under white light for 1 h to activate the PDA. The test chambers were then placed back under ambient light, and after 24 h, copepod mortality was assessed as above.
Results and discussion
Effect of illumination on the lifetime of photosensitisers
To determine the most effective concentrations of MB and NFR for use in the toxicity experiments with A. clausi, a range of concentrations of both photosensitisers were screened. Their response to irradiation for 120 minutes from a visible light source was monitored. MB and NFR were studied from 0.01 µM to 100 µM, these concentrations had favourable absorption and emission spectra without any quenching.
Within experimental error, the fluorescence of MB (10 μM) did not decrease after 60 minutes illumination when exposed to visible light ( Figure 1a ). In 
Determination of singlet oxygen production
An important factor in the use of photosensitisers is their ability to produce singlet oxygen. This is the toxic element and the production of singlet oxygen needs to be determined in order to determine whether the photosensitiers Singlet oxygen is the lowest electronically excited state and a mutagenic form of molecular oxygen [34] . Structurally NFR is more susceptible to alteration via reaction with singlet oxygen and this is observed with a decrease in the fluorescence of NFR.
PDA toxicity to Acartia clausi
Copepod mortality rates following 24 h exposure to MB, NFR and the "cocktail" under ambient light and darkness were compared with the results of tests that included a light activation period of 1 h (Fig. 4a-c Mortality rates were low (<15%) in all NFR concentrations under all treatment conditions, and light activation did not increase the toxicity of NFR to adult copepods (Fig. 4b ). This may be because the NFR flocculated out of solution in the higher concentrations and was unavailable for uptake by the copepods, or because of lower singlet oxygen production (Fig. 3b) Toxicity of the PDA "cocktail" (NFR/MB) to adult A. clausi increased greatly when the exposure duration included a 1 h light activation period (Fig. 4c) .
At a concentration of 10 M for emamectin benzoate and cypermethrin respectively. In the present work, toxicity was determined over a shorter period (24h) but even so the concentrations were much higher indicating that the PDAs are less toxic than the current generation of active-ingredients. Whether this is a beneficial attribute requires to be established in further testing (section 3.4).
Photosensitisers for Sealice control
Acartia clausi was used as a model for copepod sea lice in order to test the concept of the use of photosensitisers for the control of sea lice. As it is not possible to conduct experiments on post-larval phases of sea lice except on infected fish, the next step would be to test the relative toxicity of these photosensitisers to sea lice and infected salmonid hosts. This would establish whether a therapeutic window exists i.e. whether there is a sufficient difference in toxicity towards the parasites and their hosts to allow effective treatment. The sensitivity of the therapeutic window to other environmental parameters would also require to be determined -for example, hydrogen peroxide has been used as a sea lice treatment but has limited use in late summer as its therapeutic window diminishes to zero at around 14°C water temperature [35] . In the host fish, not only acute toxicity but also chronic effects, such as colour and taint, would require study. Assuming such studies proved positive, and the photosensitisers were shown to be relatively safe in terms of fish health and residues, a potential product developer would need to research formulation and application technologies and provide commercial-scale trial data to provide the information required for the Marketing Authorisation process. Like hydrogen peroxide, the photosensitisers examined here are relatively cheap generic products, and the protect-able intellectual property would likely reside in the specific formulation and treatment process developed.
Conclusions
The use of photochemically active biocides for the treatment of a marine copepod, which is a model of parasitic sea lice has been demonstrated. The process was effective when methylene blue and a mixture of methylene blue and nuclear fast red reagents were irradiated with visible light. Nuclear fast red was however less effective with little evidence of copepod mortality achieved even after 60 minutes irradiation. The results of this study would suggest that photochemical activation and subsequent photodegradation of PDAs may represent a controllable and environmentally benign option for control of these parasites or other pest organisms in aquaculture. However, there are significant challenges that must be overcome before any new product can be brought into the market including: efficacy, fish safety, environmental safety and the development of a patentable application. The growing resistance to the few existing products for sea lice treatment [36] may incentivise a potential developer to undertake the first stages of this process. 
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